Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pneumonia Guidances Revisited: FDA Cmte. To Weigh Study Design Issues Again

Oct 03 2011

• By Sue Sutter

Related Content

FDA Panel Offers Specifics For Revised CAP Trial Guidance, No Big Changes

Apr 07 2008

CABP Clinical Response Endpoint Gets A Boost At Ceftaroline Advisory Panel

Sep 07 2010

Guidance In The Works For Unmet Need In Serious Bacterial Infections

Sep 26 2011

CAP Drugs Must Meet Stricter Noninferiority Criteria Under Draft FDA Guidance

Jun 08 2009

FDA Raises Breakpoints In Final Labeling For Forest's Ceftaroline

Nov 08 2010

Hospital-Acquired Pneumonia Is Life Or Death, FDA Says; Recommends Sole Primary Endpoint

Dec 07 2010

Advisory Committee Splits The Difference On CABP Trials

Dec 21 2009

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window